Isleworth Healthcare Acquisition Corp.
Isleworth Healthcare Acquisition Corp. Fundamental Analysis
Isleworth Healthcare Acquisition Corp. (ISLE) shows weak financial fundamentals with a PE ratio of 21.40, profit margin of 0.00%, and ROE of 10.61%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 50.7/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze ISLE's fundamental strength across five key dimensions:
Efficiency Score
WeakISLE struggles to generate sufficient returns from assets.
Valuation Score
ExcellentISLE trades at attractive valuation levels.
Growth Score
ModerateISLE shows steady but slowing expansion.
Financial Health Score
ExcellentISLE maintains a strong and stable balance sheet.
Profitability Score
WeakISLE struggles to sustain strong margins.
Key Financial Metrics
Is ISLE Expensive or Cheap?
P/E Ratio
ISLE trades at 21.40 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, ISLE's PEG of 0.21 indicates potential undervaluation.
Price to Book
The market values Isleworth Healthcare Acquisition Corp. at 1.14 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 0.04 times EBITDA. This is generally considered low.
How Well Does ISLE Make Money?
Net Profit Margin
For every $100 in sales, Isleworth Healthcare Acquisition Corp. keeps $0.00 as profit after all expenses.
Operating Margin
Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $10.61 in profit for every $100 of shareholder equity.
ROA
Isleworth Healthcare Acquisition Corp. generates $5.09 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $-0.04 in free cash annually.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
21.40
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.21
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.14
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.10
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.11
vs 25 benchmark
ROA
Return on assets percentage
0.05
vs 25 benchmark
ROCE
Return on capital employed
-0.00
vs 25 benchmark
How ISLE Stacks Against Its Sector Peers
| Metric | ISLE Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 21.40 | 18.66 | Worse (Expensive) |
| ROE | 10.61% | 804.00% | Weak |
| Net Margin | 0.00% | 2258.00% | Weak |
| Debt/Equity | 0.00 | 1.03 | Strong (Low Leverage) |
| Current Ratio | 3.10 | 662.03 | Strong Liquidity |
| ROA | 5.09% | -24049.00% (disorted) | Weak |
ISLE outperforms its industry in 2 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Isleworth Healthcare Acquisition Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical